JP2004537288A - パパイヤ輪紋ウイルス遺伝子 - Google Patents
パパイヤ輪紋ウイルス遺伝子 Download PDFInfo
- Publication number
- JP2004537288A JP2004537288A JP2002582262A JP2002582262A JP2004537288A JP 2004537288 A JP2004537288 A JP 2004537288A JP 2002582262 A JP2002582262 A JP 2002582262A JP 2002582262 A JP2002582262 A JP 2002582262A JP 2004537288 A JP2004537288 A JP 2004537288A
- Authority
- JP
- Japan
- Prior art keywords
- papaya
- plant
- dna construct
- dna
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 235000009467 Carica papaya Nutrition 0.000 title claims abstract description 90
- 241000700605 Viruses Species 0.000 title claims abstract description 88
- 108090000623 proteins and genes Proteins 0.000 title claims description 77
- 240000006432 Carica papaya Species 0.000 title description 52
- 241000196324 Embryophyta Species 0.000 claims abstract description 195
- 150000007523 nucleic acids Chemical group 0.000 claims abstract description 89
- 230000009261 transgenic effect Effects 0.000 claims abstract description 86
- 101710132601 Capsid protein Proteins 0.000 claims abstract description 41
- 101710094648 Coat protein Proteins 0.000 claims abstract description 41
- 101710125418 Major capsid protein Proteins 0.000 claims abstract description 41
- 101710141454 Nucleoprotein Proteins 0.000 claims abstract description 41
- 101710083689 Probable capsid protein Proteins 0.000 claims abstract description 41
- 238000000034 method Methods 0.000 claims abstract description 41
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 claims abstract description 30
- 241000219173 Carica Species 0.000 claims abstract 67
- 108020004414 DNA Proteins 0.000 claims description 183
- 210000004027 cell Anatomy 0.000 claims description 103
- 102000039446 nucleic acids Human genes 0.000 claims description 73
- 108020004707 nucleic acids Proteins 0.000 claims description 73
- 241000723990 Papaya ringspot virus Species 0.000 claims description 59
- 102000053602 DNA Human genes 0.000 claims description 43
- 239000002773 nucleotide Substances 0.000 claims description 32
- 125000003729 nucleotide group Chemical group 0.000 claims description 32
- 230000003584 silencer Effects 0.000 claims description 24
- 239000013604 expression vector Substances 0.000 claims description 21
- 150000001413 amino acids Chemical class 0.000 claims description 20
- 230000001105 regulatory effect Effects 0.000 claims description 19
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 18
- 230000001580 bacterial effect Effects 0.000 claims description 16
- 230000001131 transforming effect Effects 0.000 claims description 15
- 238000004458 analytical method Methods 0.000 claims description 11
- 238000009396 hybridization Methods 0.000 claims description 11
- 230000004927 fusion Effects 0.000 claims description 10
- 230000000692 anti-sense effect Effects 0.000 claims description 8
- 108700005077 Viral Genes Proteins 0.000 claims description 7
- 238000013518 transcription Methods 0.000 claims description 7
- 230000035897 transcription Effects 0.000 claims description 7
- 230000030279 gene silencing Effects 0.000 claims description 5
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 230000032361 posttranscriptional gene silencing Effects 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 2
- 108020005120 Plant DNA Proteins 0.000 claims description 2
- 210000005253 yeast cell Anatomy 0.000 claims 11
- 108020005202 Viral DNA Proteins 0.000 claims 1
- 102000034287 fluorescent proteins Human genes 0.000 claims 1
- 108091006047 fluorescent proteins Proteins 0.000 claims 1
- 206010034133 Pathogen resistance Diseases 0.000 abstract description 5
- 238000002955 isolation Methods 0.000 abstract description 3
- 239000013256 coordination polymer Substances 0.000 description 47
- 239000013598 vector Substances 0.000 description 36
- 239000012634 fragment Substances 0.000 description 35
- 230000014509 gene expression Effects 0.000 description 34
- 230000009466 transformation Effects 0.000 description 28
- 210000001519 tissue Anatomy 0.000 description 19
- 102000004169 proteins and genes Human genes 0.000 description 18
- 239000013612 plasmid Substances 0.000 description 16
- 238000010367 cloning Methods 0.000 description 13
- 230000003612 virological effect Effects 0.000 description 13
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 12
- 210000002257 embryonic structure Anatomy 0.000 description 11
- 108091008146 restriction endonucleases Proteins 0.000 description 10
- 101150083464 CP gene Proteins 0.000 description 9
- 241000710078 Potyvirus Species 0.000 description 9
- 230000003321 amplification Effects 0.000 description 9
- 238000003776 cleavage reaction Methods 0.000 description 9
- 230000001939 inductive effect Effects 0.000 description 9
- 208000015181 infectious disease Diseases 0.000 description 9
- 238000003199 nucleic acid amplification method Methods 0.000 description 9
- 230000007017 scission Effects 0.000 description 9
- 108700019146 Transgenes Proteins 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 108020004999 messenger RNA Proteins 0.000 description 7
- 241000894007 species Species 0.000 description 7
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 6
- 239000003184 complementary RNA Substances 0.000 description 6
- 210000001161 mammalian embryo Anatomy 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 210000001938 protoplast Anatomy 0.000 description 6
- 230000008929 regeneration Effects 0.000 description 6
- 238000011069 regeneration method Methods 0.000 description 6
- 108020005544 Antisense RNA Proteins 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 230000014616 translation Effects 0.000 description 5
- 108020004705 Codon Proteins 0.000 description 4
- 241000724252 Cucumber mosaic virus Species 0.000 description 4
- 235000009854 Cucurbita moschata Nutrition 0.000 description 4
- 206010020649 Hyperkeratosis Diseases 0.000 description 4
- 241000723873 Tobacco mosaic virus Species 0.000 description 4
- 241000016010 Tomato spotted wilt orthotospovirus Species 0.000 description 4
- 241000723854 Zucchini yellow mosaic virus Species 0.000 description 4
- 238000010353 genetic engineering Methods 0.000 description 4
- 239000000411 inducer Substances 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 238000010369 molecular cloning Methods 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000000392 somatic effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000010474 transient expression Effects 0.000 description 4
- 238000013519 translation Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000701489 Cauliflower mosaic virus Species 0.000 description 3
- 108091026890 Coding region Proteins 0.000 description 3
- 240000001980 Cucurbita pepo Species 0.000 description 3
- 241000712893 Impatiens necrotic spot virus Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 241000712894 Orthotospovirus Species 0.000 description 3
- 108020004511 Recombinant DNA Proteins 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000012226 gene silencing method Methods 0.000 description 3
- 239000005090 green fluorescent protein Substances 0.000 description 3
- 239000004009 herbicide Substances 0.000 description 3
- 230000014726 immortalization of host cell Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 241000589158 Agrobacterium Species 0.000 description 2
- 241001600407 Aphis <genus> Species 0.000 description 2
- 235000000832 Ayote Nutrition 0.000 description 2
- 108700003860 Bacterial Genes Proteins 0.000 description 2
- 241000219172 Caricaceae Species 0.000 description 2
- 235000009852 Cucurbita pepo Nutrition 0.000 description 2
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 2
- 208000035240 Disease Resistance Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 108091029865 Exogenous DNA Proteins 0.000 description 2
- 102000053187 Glucuronidase Human genes 0.000 description 2
- 108010060309 Glucuronidase Proteins 0.000 description 2
- 241000725580 Groundnut ringspot virus Species 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 108090001074 Nucleocapsid Proteins Proteins 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 108700008625 Reporter Genes Proteins 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000893966 Trichophyton verrucosum Species 0.000 description 2
- 241001310178 Watermelon mosaic virus Species 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000034303 cell budding Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 230000002074 deregulated effect Effects 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000008659 phytopathology Effects 0.000 description 2
- 238000003976 plant breeding Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 230000007026 protein scission Effects 0.000 description 2
- 235000015136 pumpkin Nutrition 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000030118 somatic embryogenesis Effects 0.000 description 2
- 235000020354 squash Nutrition 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- 239000010937 tungsten Substances 0.000 description 2
- 230000029812 viral genome replication Effects 0.000 description 2
- KZMAWJRXKGLWGS-UHFFFAOYSA-N 2-chloro-n-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-n-(3-methoxypropyl)acetamide Chemical compound S1C(N(C(=O)CCl)CCCOC)=NC(C=2C=CC(OC)=CC=2)=C1 KZMAWJRXKGLWGS-UHFFFAOYSA-N 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 206010068051 Chimerism Diseases 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 241000219122 Cucurbita Species 0.000 description 1
- 101150074155 DHFR gene Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 101100437498 Escherichia coli (strain K12) uidA gene Proteins 0.000 description 1
- 101710129170 Extensin Proteins 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 108020005350 Initiator Codon Proteins 0.000 description 1
- 101100288095 Klebsiella pneumoniae neo gene Proteins 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010068052 Mosaicism Diseases 0.000 description 1
- 108020004485 Nonsense Codon Proteins 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 241000150350 Peribunyaviridae Species 0.000 description 1
- 108700023158 Phenylalanine ammonia-lyases Proteins 0.000 description 1
- 108010076039 Polyproteins Proteins 0.000 description 1
- 108091034057 RNA (poly(A)) Proteins 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 241001664469 Tibicina haematodes Species 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 108700002693 Viral Replicase Complex Proteins Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000007248 cellular mechanism Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 1
- 239000004062 cytokinin Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000003831 deregulation Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 108010060641 flavanone synthetase Proteins 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Natural products O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000010324 immunological assay Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000001739 intranuclear inclusion body Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 108010058731 nopaline synthase Proteins 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- -1 phenolic compounds Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000009894 physiological stress Effects 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 102000037983 regulatory factors Human genes 0.000 description 1
- 108091008025 regulatory factors Proteins 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000012882 rooting medium Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 229960000268 spectinomycin Drugs 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- 230000005740 tumor formation Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 101150085703 vir gene Proteins 0.000 description 1
- 230000006648 viral gene expression Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 244000052613 viral pathogen Species 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/34011—Potyviridae
- C12N2770/34022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Seeds, Soups, And Other Foods (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28300701P | 2001-04-11 | 2001-04-11 | |
| PCT/US2002/011805 WO2002083925A2 (en) | 2001-04-11 | 2002-04-11 | Papaya ringspot virus genes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008152397A Division JP2008283978A (ja) | 2001-04-11 | 2008-06-11 | パパイヤ輪紋ウイルス遺伝子 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004537288A true JP2004537288A (ja) | 2004-12-16 |
| JP2004537288A5 JP2004537288A5 (OSRAM) | 2006-01-05 |
Family
ID=23084080
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002582262A Withdrawn JP2004537288A (ja) | 2001-04-11 | 2002-04-11 | パパイヤ輪紋ウイルス遺伝子 |
| JP2008152397A Pending JP2008283978A (ja) | 2001-04-11 | 2008-06-11 | パパイヤ輪紋ウイルス遺伝子 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008152397A Pending JP2008283978A (ja) | 2001-04-11 | 2008-06-11 | パパイヤ輪紋ウイルス遺伝子 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7078586B2 (OSRAM) |
| JP (2) | JP2004537288A (OSRAM) |
| AU (1) | AU2002307322B9 (OSRAM) |
| BR (1) | BR0208888A (OSRAM) |
| MX (1) | MXPA03009235A (OSRAM) |
| WO (1) | WO2002083925A2 (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7071377B2 (en) * | 2001-04-11 | 2006-07-04 | Cornell Research Foundation, Inc. | Method to control the ripening of papaya fruit and confer disease resistance to papaya plants |
| CN1257283C (zh) | 2003-01-21 | 2006-05-24 | 中国科学院遗传与发育生物学研究所 | 一种培育高抗病毒转基因植物的方法与应用 |
| CN110564891A (zh) * | 2019-08-22 | 2019-12-13 | 桂林莱茵生物科技股份有限公司 | 一种快速检测罗汉果番木瓜环斑病毒的方法 |
| CN114426973B (zh) * | 2022-02-22 | 2023-10-24 | 云南中烟工业有限责任公司 | 一种烟草输导蛋白相关基因NtImpα4及其应用 |
| CN117778620B (zh) * | 2024-02-27 | 2024-06-11 | 中国热带农业科学院三亚研究院 | 区分番木瓜环斑病毒抗性品种的dna探针、试剂盒及方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0699757A1 (en) | 1988-08-19 | 1996-03-06 | Asgrow Seed Company | Potyvirus coat protein genes and plants transformed therewith |
| DE69331050T2 (de) | 1992-02-19 | 2002-06-20 | The State Of Oregon Acting By And Through The Oregon Stateboard Of Higher Education On Behalf Of The Universtiy Of Oregon, Corvallis | Produktion virus-resistenter pflanzen durch einführung von nicht-translatierbarer viraler plus-strang-rna |
| US6002072A (en) | 1994-12-30 | 1999-12-14 | Seminis Vegetable Seeds, Inc. | Coat protein gene for the FLA83 W strain of papaya ringspot virus |
| US6046384A (en) | 1995-06-07 | 2000-04-04 | Seminis Vegetable Seeds, Inc. | Papaya ringspot virus NIa protease gene |
| AU729306B2 (en) * | 1997-02-19 | 2001-02-01 | Cornell Research Foundation Inc. | Dna construct to confer multiple traits on plants |
| US7071377B2 (en) | 2001-04-11 | 2006-07-04 | Cornell Research Foundation, Inc. | Method to control the ripening of papaya fruit and confer disease resistance to papaya plants |
| US6903238B2 (en) | 2001-12-13 | 2005-06-07 | Wyeth | Substituted indenones as estrogenic agents |
-
2002
- 2002-04-11 MX MXPA03009235A patent/MXPA03009235A/es active IP Right Grant
- 2002-04-11 BR BR0208888-6A patent/BR0208888A/pt not_active Application Discontinuation
- 2002-04-11 US US10/121,209 patent/US7078586B2/en not_active Expired - Fee Related
- 2002-04-11 JP JP2002582262A patent/JP2004537288A/ja not_active Withdrawn
- 2002-04-11 WO PCT/US2002/011805 patent/WO2002083925A2/en not_active Ceased
- 2002-04-11 AU AU2002307322A patent/AU2002307322B9/en not_active Ceased
-
2006
- 2006-07-11 US US11/456,788 patent/US7553668B2/en not_active Expired - Fee Related
-
2008
- 2008-06-11 JP JP2008152397A patent/JP2008283978A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008283978A (ja) | 2008-11-27 |
| US7553668B2 (en) | 2009-06-30 |
| WO2002083925A3 (en) | 2009-07-16 |
| AU2002307322B9 (en) | 2008-03-20 |
| MXPA03009235A (es) | 2004-01-29 |
| WO2002083925A2 (en) | 2002-10-24 |
| AU2002307322B2 (en) | 2007-09-13 |
| US7078586B2 (en) | 2006-07-18 |
| US20070089197A1 (en) | 2007-04-19 |
| BR0208888A (pt) | 2006-02-07 |
| US20030172397A1 (en) | 2003-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0800582B1 (en) | Transgenic plants expressing dna constructs containing a plurality of genes to impart virus resistance | |
| US6903248B2 (en) | DNA constructs and methods to impart resistance to at least one virus on plants | |
| US6342655B1 (en) | Plants resistant to WT strains of cucumber mosaic virus | |
| CA2095109C (en) | Process for production of exogenous gene or its product in plant cells | |
| AU707753B2 (en) | Papaya ringspot virus NIa protease gene | |
| JP2008283978A (ja) | パパイヤ輪紋ウイルス遺伝子 | |
| US6015942A (en) | Transgenic plants exhibiting heterologous virus resistance | |
| EP0938574B1 (en) | Method for inducing viral resistance into a plant | |
| US20020059660A1 (en) | Transgenic plants expressing DNA constructs containing a plurality of genes to impart virus resistance | |
| US20030190700A1 (en) | Synthetic nucleic acid molecule for imparting multiple traits | |
| EP1358341B1 (en) | Methods for generating resistance against cgmmv in plants | |
| AU2002307322A1 (en) | Papaya ringspot virus genes | |
| US5939603A (en) | Plants transformed with a potato virus Y gene | |
| US8901372B2 (en) | Plant resistance to banana bunchy top virus | |
| US6548742B2 (en) | Development of resistance to raspberry bushy dwarf virus | |
| PrimaryTransformants | Resistance to Tospoviruses in Nicotiana benthamiana Transformed with the N Gene of Tomato Spotted Wilt Virus: Correlation Between Transgene Expression and Protection In PrimaryTransformants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050408 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050620 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070928 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20071220 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20071228 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080121 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080213 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080611 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080717 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080702 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20080805 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080908 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20081205 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20081212 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090106 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090114 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090205 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090213 |
|
| A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20090319 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20101104 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20101109 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20101208 |